Evaluation of ionotropic cross-linked chitosan/gelatin B microspheres of tramadol hydrochloride

AAPS PharmSciTech

Volumn 12, Issue 1, 2011, Pages 28-34

  Basu, Sanat Kumar ^a   Kavitha, Kunchu ^b   Rupeshkumar, Mani ^b  

^a JADAVPUR UNIVERSITY   (India)

^b BHARATHI COLLEGE OF PHARMACY   (India)

Author keywords

chitosan; complex coacervation; gelatin B; microspheres; tramadol hydrochloride

Indexed keywords

CHITOSAN; COPOLYMER; GELATIN; MICROSPHERE; POLYMER; TRAMADOL;

ARTICLE; BIODEGRADABILITY; CROSS LINKING; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; FOURIER TRANSFORM MASS SPECTROMETRY; GELATION; IN VITRO STUDY; PARTICLE SIZE; PATIENT COMPLIANCE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY; X RAY DIFFRACTION;

ANALGESICS, OPIOID; CALORIMETRY, DIFFERENTIAL SCANNING; CHITOSAN; CROSS-LINKING REAGENTS; DIFFUSION; DRUG CARRIERS; GELATIN; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; POLYPHOSPHATES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TRAMADOL;

EID: 79954419874     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9537-2     Document Type: Article

References (27)

1. K Allegaert BJ Anderson R Verbesselt A Debeer J de Hoon H Devlieger, et al. 2005 Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity Br J Anaesth 95 231 239 15951326 10.1093/bja/aei170 1:STN:280:DC%2BD2Mzlt1eluw%3D%3D (Pubitemid 41487151)
2. J Varshosaz N Tavakoli F Kheirolahi 2006 Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride AAPS PharmSciTech 7 E1 E7 10.1208/pt070124
3. H Malonne M Coffiner D Fontaine, et al. 2005 Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain J Clin Pharm Ther 30 113 120 15811163 10.1111/j.1365-2710.2004. 00624.x 1:CAS:528:DC%2BD2MXktVOktLw%3D (Pubitemid 41583605)
4. P Kumar S Singh B Mishra 2009 Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology Acta Pharm 59 15 30 19304555 10.2478/v10007-009-0010-2 1:CAS:528:DC%2BD1MXktVWqu7s%3D
5. C Mattia F Coluzzi 2006 Once-daily tramadol in rheumatological pain Expert Opin Pharmacother 7 1811 1815 16925507 10.1517/14656566.7.13.1811 1:CAS:528:DC%2BD28XovVeltrs%3D
6. JC Finkel JB Rose ML Schmitz PK Birmingham GA Ulma JB Gunter, et al. 2002 An evaluation of the efficacy and tolerability of oral tramadol hydrochloride tablets for the treatment of post surgical pain in children Anesth Analg 94 1469 1473 12032009 10.1097/00000539-200206000-00017 1:CAS:528:DC%2BD38XkvFSgtb8%3D (Pubitemid 34556626)
7. 1 delivery for cartilage tissue engineering Chin Med J 120 197 203 17355821 1:CAS:528:DC%2BD2sXjtVWgtb0%3D
8. AEB Yassin IA Alsarra AM Al-Mohizea 2006 Chitosan beads as a new gastroretentive system of verapamil Sci Pharm 74 175 188 10.3797/scipharm.2006. 74.175 1:CAS:528:DC%2BD2sXhvVCqsr8%3D (Pubitemid 46129272)
9. EB Denkbas 2006 Perspectives on: chitosan drug delivery systems based on their geometries J Bioact Compat Polym 21 351 368 10.1177/0883911506066930 1:CAS:528:DC%2BD28XnsFGgs74%3D (Pubitemid 43953803)
10. C Gilberto B Moreno C Andrea R Tiziana S Santo I Valentina 2008 Toxicity and gut associated lymphoid tissue translocation of polymyxin B orally administered by alginate/chitosan microparticles in rats J Pharm Pharmacol 60 21 26
11. C Shankar B Mishra 2003 Development and in-vitro evaluation of gelatin A microspheres of Ketorolac tromethamine for intranasal administration Acta Pharm 53 101 110 (Pubitemid 36850881)
12. XZ Shu KJ Zhu 2001 Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation J Microencaspul 18 237 245 10.1080/02652040010000415 1:CAS:528:DC%2BD3MXhs1Sgurs%3D (Pubitemid 32177841)
13. RL Carmen B Roland 1996 Effect of formulation and process variables on the formation of Chitosan-gelatin coacervates Int J Pharm 135 63 72 10.1016/0378-5173(95)04347-0 (Pubitemid 26260874)
14. JA Koa HJ Park SJ Hwang JB Park JS Lee 2002 Preparation and characterization of chitosan microparticles intended for controlled drug delivery Int J Pharm 249 165 174 10.1016/S0378-5173(02)00487-8 (Pubitemid 35333443)
15. XZ Shu KJ Zhu 2000 A novel approach to prepare tripolyphasphate/chitosan complex beads for controlled release drug delivery Int J Pharm 20 51 58 10.1016/S0378-5173(00)00403-8 (Pubitemid 30364969)
16. RR Dubey RH Parikh 2003 Two-stage optimization process for formulation of Chitosan microspheres AAPS PharmSciTech 5 1 9
17. M Gandhimathi TK Ravi N Shukla 2006 Simultaneous determination of Aspirin and Clopidogrel in tablets by HPTLC method Indian Drugs 43 397 399
18. XZ Shu KJ Zhu W Song 2001 Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release Int J Pharm 212 19 28 11165817 10.1016/S0378-5173(00)00582-2 1:CAS:528:DC%2BD3MXovFWgug%3D%3D (Pubitemid 32121947)
19. AK Manna S Ray BK Gupta LK Ghosh 2005 Product development studies on control release delivery system of Nitrofurantoin J Pharm Res 4 16 18
20. AK Dash 1997 Determination of the physical state of drug in microcapsule and microsphere formulations J Microencapsul 14 101 112 8994079 10.3109/02652049709056471 1:CAS:528:DyaK2sXos1OlsQ%3D%3D
21. K Aiedeh E Ganasi I Orient V Zeeshi 1997 Chitosan microcapsules as controlled release systems for insulin J Microencapsul 14 567 576 9292433 10.3109/02652049709006810 1:CAS:528:DyaK2sXlvVSqt7o%3D (Pubitemid 27380189)
22. R Jeyanthi C Mehta BC Thanoo PP Deluca 1997 Effect of processing parameters on the properties of peptide-containing polylactic-co-glycolic acid (PLGA) microspheres J Microencapsul 14 163 174 9132468 10.3109/02652049709015330 1:CAS:528:DyaK2sXht1ykur4%3D (Pubitemid 27095967)
23. ED Denkbas M Seyyal E Piskins 1999 5-Fluorouracil loaded Chitosan microspheres for chemo embolization J Microencapsul 6 741 749 (Pubitemid 29478953)
24. RW Korsmeyer R Gurny E Doelker P Buri NA Peppas 1983 Mechanisms of solute release from porous hydrophilic polymers Int J Pharm 15 25 35 10.1016/0378-5173(83)90064-9 1:CAS:528:DyaL3sXksVens7Y%3D (Pubitemid 13092121)
25. P Costa 2001 An alternative method to the evaluation of similarity factor in dissolution testing Int J Pharm 220 77 83 11376969 10.1016/S0378-5173(01) 00651-2 1:CAS:528:DC%2BD3MXjs1yrtLg%3D (Pubitemid 32476843)
26. AS Zidan OA Sammour MA Hammad NA Megrab MD Hussain MA Khan, et al. 2006 Formulation of Anastrozole microparticles as biodegradable anti cancer drug carriers AAPS PharmSciTech 7 E1 E9 10.1208/pt070361 (Pubitemid 44144820)
27. OI Corrigan 1995 Thermal analysis of spray dried products Thermochim Acta 248 245 258 10.1016/0040-6031(94)01891-J 1:CAS:528:DyaK2MXivVOrt7o%3D